Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Methods Mol Biol ; 2625: 107-113, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36653637

RESUMO

High-performance thin layer chromatography (HPTLC) is a very robust, fast, and inexpensive technique that enables separation of complex mixtures. Here, we describe the analytical separation of glucosylceramide and galactosylceramide by HPTLC. This technique can be used for quantitation purposes but also with small modification for subsequent mass spectrum analysis for structural determination.


Assuntos
Cerebrosídeos , Glucosilceramidas , Cromatografia em Camada Fina/métodos , Galactosilceramidas , Espectrometria de Massas
2.
Biomed Res Int ; 2019: 5025398, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31737666

RESUMO

Debridement of the bone surface during a surgical fusion procedure initiates an injury response promoting a healing cascade of molecular mediators released over time. Autologous grafts offer natural scaffolding to fill the bone void and to provide local bone cells. Commercial bone grafting products such as allografts, synthetic bone mineral products, etc., are used to supplement or to replace autologous grafts by supporting osteoinductivity, osteoconductivity, and osteogenesis at the surgical site. To assure osteogenic potential, preservation of allogeneic cells with cryoprotectants has been developed to allow for long-term storage and thus delivery of viable bone cells to the surgical site. Dimethyl sulfoxide (DMSO) is an intracellular cryoprotectant commonly used because it provides good viability of the cells post-thaw. However, there is known cytotoxicity reported for DMSO when cells are stored above cryogenic temperatures. For most cellular bone graft products, the cryoprotectant is incorporated with the cells into the other mineralized bone and demineralized bone components. During thawing, the DMSO may not be sufficiently removed from allograft products compared to its use in a cell suspension where removal by washing and centrifugation is available. Therefore, both the allogeneic cell types in the bone grafting product and the local cell types at the bone grafting site could be affected as cytotoxicity varies by cell type and by DMSO content according to reported studies. Overcoming cytotoxicity may be an additional challenge in the formation of bone at a wound or surgical site. Other extracellular cryoprotectants have been explored as alternatives to DMSO which preserve without entering the cell membrane, thereby providing good cellular viability post-thaw and might abrogate the cytotoxicity concerns.


Assuntos
Transplante Ósseo/métodos , Criopreservação/métodos , Crioprotetores/farmacologia , Osteogênese/efeitos dos fármacos , Aloenxertos/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Humanos , Osteócitos/efeitos dos fármacos , Osteogênese/fisiologia , Transplante Homólogo/métodos
3.
Methods Mol Biol ; 1609: 57-63, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28660574

RESUMO

High-performance thin-layer chromatography (HPTLC) is a very robust, fast, and inexpensive technique that enables separation of complex mixtures. Here, we describe the analytical separation of glucosylceramide and galactosylceramide by HPTLC. This technique can be used for quantitation purposes but also with small modification for subsequent mass spectrum analyses for structural determination.


Assuntos
Cerebrosídeos/isolamento & purificação , Cromatografia Líquida de Alta Pressão , Cromatografia Líquida de Alta Pressão/métodos , Galactosilceramidas/isolamento & purificação , Glucosilceramidas/isolamento & purificação , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
4.
Blood ; 125(4): 649-57, 2015 Jan 22.
Artigo em Inglês | MEDLINE | ID: mdl-25381061

RESUMO

Human germinal center-associated lymphoma (HGAL) is specifically expressed only in germinal center (GC) B lymphocytes and GC-derived lymphomas. HGAL protein decreases lymphocyte motility by inhibiting the ability of myosin to translocate actin via direct interaction with F-actin and myosin II and by activating RhoA signaling via direct interactions with RhoA-specific guanine nucleotide exchange factors. HGAL protein also regulates B-cell receptor (BCR) signaling by directly binding to and enhancing Syk kinase activity and activation of its downstream effectors. Herein we demonstrate that HGAL protein can be myristoylated and palmitoylated and that these modifications localize HGAL to cellular membrane raft microdomains with distinct consequences for BCR signaling and chemoattractant-induced cell mobility. In BCR signaling, raft localization of HGAL facilitates interaction with Syk and modulation of the BCR activation and signaling, which induces HGAL phosphorylation and redistribution from lipid raft to bulk membrane and cytoplasm, followed by degradation. In contrast, HGAL myristoylation and palmitoylation avert its inhibitory effects on chemoattractant-induced cell motility. These findings further elucidate the growing and complex role of HGAL in B-cell biology and suggest that membrane-bound and cytoplasmic HGAL protein differently regulates distinct biological processes.


Assuntos
Linfócitos B/metabolismo , Microdomínios da Membrana/metabolismo , Proteínas de Neoplasias/metabolismo , Receptores de Antígenos de Linfócitos B/metabolismo , Transdução de Sinais/fisiologia , Actinas/genética , Actinas/imunologia , Actinas/metabolismo , Linfócitos B/citologia , Linfócitos B/imunologia , Movimento Celular/genética , Movimento Celular/imunologia , Fatores Quimiotáticos/genética , Fatores Quimiotáticos/imunologia , Fatores Quimiotáticos/metabolismo , Citoplasma/genética , Citoplasma/imunologia , Citoplasma/metabolismo , Células HeLa , Humanos , Peptídeos e Proteínas de Sinalização Intracelular/genética , Peptídeos e Proteínas de Sinalização Intracelular/imunologia , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Lipoilação/genética , Lipoilação/imunologia , Microdomínios da Membrana/genética , Microdomínios da Membrana/imunologia , Proteínas dos Microfilamentos , Miosina Tipo II/genética , Miosina Tipo II/imunologia , Miosina Tipo II/metabolismo , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/imunologia , Transporte Proteico/fisiologia , Proteínas Tirosina Quinases/genética , Proteínas Tirosina Quinases/imunologia , Proteínas Tirosina Quinases/metabolismo , Proteólise , Receptores de Antígenos de Linfócitos B/genética , Receptores de Antígenos de Linfócitos B/imunologia , Quinase Syk , Proteínas rho de Ligação ao GTP/genética , Proteínas rho de Ligação ao GTP/imunologia , Proteínas rho de Ligação ao GTP/metabolismo , Proteína rhoA de Ligação ao GTP
5.
Bioorg Med Chem Lett ; 22(17): 5532-5, 2012 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-22868229

RESUMO

ERBB receptor kinases play a crucial role in normal development and cancer malignancies. A broad range of modifications creates receptor subpopulations with distinct functional properties in live cells. Their apparent activation state, typically assayed by tyrosine phosphorylation of substrates, reflects a complex equilibrium of competing reactions. With the aim of developing optical tools to investigate ERBB populations and their state of activation, we have synthesized a fluorescent 'turn-on' probe, DMAQ, targeting the ERBB ATP binding pocket. Upon binding, probe emission increases due to the hydrophobic environment and restricted geometry of the ERBB2 kinase domain, facilitating the analysis of receptor states at low occupancy and without the removal of unbound probes. Cellular ERBB2 autophosphorylation is inhibited with saturation kinetics that correlate with the increase in probe fluorescence. Thus, DMAQ is an example of a new generation of 'turn-on' probes with potential applications in querying receptor kinase populations both in vitro and in live cells.


Assuntos
Trifosfato de Adenosina/metabolismo , Corantes Fluorescentes/metabolismo , Quinazolinas/metabolismo , Receptor ErbB-2/metabolismo , Trifosfato de Adenosina/análogos & derivados , Sítios de Ligação , Neoplasias da Mama/metabolismo , Linhagem Celular Tumoral , Sobrevivência Celular , Feminino , Corantes Fluorescentes/química , Humanos , Modelos Moleculares , Fosforilação , Quinazolinas/química , Receptor ErbB-2/análise , Espectrometria de Fluorescência
6.
J Control Release ; 148(2): 234-40, 2010 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-20728487

RESUMO

The preparation and properties of poly(vinyl benzoate) nanoparticle suspensions as molecular carriers are described for the first time. These nanoparticles can be formed by nanoprecipitation of commercial poly(vinyl benzoate) in water using Pluronic F68 as surfactant, to create spherical nanostructures measuring 200-250nm in diameter. These nanoparticles are stable in phosphate buffer and blood serum, and only slowly degrade in the presence of esterases. Pluronic F68 stabilizes the nanoparticle and also protects it from enzymatic degradation. Up to 1.6% by weight of a lipid-soluble molecule such as coumarin-6 can be introduced into the nanoparticle during nanoprecipitation, compared to a water-soluble compound (5(6)-carboxyfluorescein) which gave almost no loading. Kinetics experiments in phosphate buffer indicate that 78% of the coumarin-6 was encapsulated within the polymer matrix of the nanoparticle, and the residual 22% of coumarin-6 was surface-bound and quickly released. The nanoparticles are non-toxic in vitro towards human epithelial cells (IC(50)>1000µg/mL) and primary bovine aortic endothelial cells (IC(50)>500µg/mL), and non-bactericidal against a selection of representative test microbes (MIC >250µg/mL). These properties suggest that the poly(vinyl benzoate) nanoparticles may be suitable carriers for molecular delivery of lipophilic small molecules such as pharmaceutical and imaging agents.


Assuntos
Portadores de Fármacos , Nanopartículas , Polivinil/síntese química , Animais , Bovinos , Linhagem Celular , Sobrevivência Celular , Precipitação Química , Química Farmacêutica , Cumarínicos/química , Preparações de Ação Retardada , Relação Dose-Resposta a Droga , Composição de Medicamentos , Células Endoteliais/efeitos dos fármacos , Escherichia coli K12/efeitos dos fármacos , Fluoresceínas/química , Corantes Fluorescentes/química , Humanos , Hidrólise , Concentração Inibidora 50 , Queratinócitos/efeitos dos fármacos , Cinética , Testes de Sensibilidade Microbiana , Nanotecnologia , Tamanho da Partícula , Poloxâmero/química , Polivinil/toxicidade , Solubilidade , Staphylococcus aureus/efeitos dos fármacos , Tensoativos/química , Tecnologia Farmacêutica/métodos , Tiazóis/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...